CyD1-siRNA (Immune Disease Institute)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCyD1-siRNA (Immune Disease Institute)
Drug Alias Namecyclin D1-siRNA (Immune Disease Institute)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionIntegrin alpha-4/beta-7 modulatorsMucosal addressin cell adhesion molecule-1 modulatorsIntegrin beta-7 modulators +[4] 
TargetsIntegrin beta-7Mucosal addressin cell adhesion molecule-1Cyclin D1 +[4] 
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Disease Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune Disease Institute Inc
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A